Please login to the form below

Not currently logged in
Email:
Password:

Cinven

This page shows the latest Cinven news and features for those working in and with pharma, biotech and healthcare.

Stada's €4.1bn takeover goes through

Stada's €4.1bn takeover goes through

After months of wrangling, German pharma company Stada has finally come under new ownership after a successful tender by private equity firms Bain and Cinven. ... The buyout - which is the largest for a European-listed company for years - came after

Latest news

  • Time running out on new Stada takeover bid Time running out on new Stada takeover bid

    With a deadline looming on Wednesday, only a third of shareholders in German pharma company Stada have accepted the takeover bid by Bain and Cinven. ... Bain and Cinven narrowly failed to reach the required acceptance threshold for an earlier offer,

  • Trouble at the top of Stada as Bain and Cinven mull fresh bid Trouble at the top of Stada as Bain and Cinven mull fresh bid

    Trouble at the top of Stada as Bain and Cinven mull fresh bid. ... The chief executive and finance chief of Stada have stepped down in the wake of the failed takeover by private equity firms Bain and Cinven, citing "personal reasons".

  • No deal for Stada as private equity takeover bid collapses No deal for Stada as private equity takeover bid collapses

    Bain Capital and Cinven's planned buyout of Germany's Stada has failed at the last hurdle, with too few of Stada's shareholders agreeing to the deal by the deadline. ... Stada's board had lent its support to the Bain-Cinven offer over a rival 58 per

  • Private equity firms agree deal to take over Stada Private equity firms agree deal to take over Stada

    Private equity firms agree deal to take over Stada. Cinven and Bain Capital beat out competition from Advent International. ... Cinven and Bain Capital made what Stada said was the "most financially appealing offer" of 66 per share, topping an earlier

  • Stada opens books to let formal bidding commence Stada opens books to let formal bidding commence

    Stada opens books to let formal bidding commence. Cinven, Advent International and Bain Capital now have opportunity to revise their bids. ... The three interested parties - confirmed as Cinven, Advent International and Bain Capital - will now all

More from news
Approximately 7 fully matching, plus 4 partially matching documents found.

Latest Intelligence

  • Deal Watch - May 2017 Deal Watch - May 2017

    The 2008 financial crash is a salutary reminder. Given this background what do we make of the deal where two private equity companies, Bain and Cinven, joined forces to acquire Stada ... the company and improve its financial results ready for

  • Deal Watch February 2017 Deal Watch February 2017

    Earlier in the month the private equity (PE) firm Cinven offered 56 a share to acquire Stada but this has been topped by a binding offer from another PE company, Advent

  • Pharma deals in September 2015 Pharma deals in September 2015

    Transformational deals. The two largest deals announced this month were Cinven's sale of Amdipharm Mercury (AMCo) to Concordia Healthcare and Actelion's move to acquire ZS Pharma, at $3.5bn

  • Deal Watch table for February 2014 Deal Watch table for February 2014

    1, 225. Medpace / Cinven. Acquisition – majority shareholding. US mid-sized CRO with global presence.

  • Pharma deals during October 2012 Pharma deals during October 2012

    680. Amdipharm / Cinven. Acquisition. Portfolio of off-patent “ legacy products”.

More from intelligence
Approximately 0 fully matching, plus 5 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Makara Health

Independent healthcare communications agency with a passion to develop inspirational ideas that create sustained and positive change. Whether it is...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics